Streetbeat News

Earnings

OSW

OneSpaWorld Holdings (NASDAQ:OSW) reported Q3 2023 earnings of $0.22 per share, beating the analyst consensus estimate of $0.17 by 29.41%. This is a 69.23% increase from the same period last year. The company also reported quarterly sales of $216.27 million, beating the analyst consensus estimate of $210.23 million by 2.87%. This is a 33.26% increase from the same period last year.

Portfolio Pulse from saritha@benzinga.com

November 01, 2023 | 10:47 am

TRI

Thomson Reuters has reiterated its FY23 revenue growth forecast of 3.0%-3.5% year-on-year, against an estimate of $6.83 billion. The company also expects organic revenue growth of 6.5%-7.0% and an adjusted EBITDA margin of around 44%.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:47 am

TRI

Thomson Reuters reported Q3 earnings of $0.82 per share, beating the analyst consensus estimate of $0.71 by 15.49%. This is a 38.98% increase from the same period last year. However, the company's quarterly sales of $1.59 billion missed the analyst consensus estimate of $1.61 billion by 0.99%. This is a 1.27% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:42 am

ETR

Entergy has revised its FY23 adjusted EPS guidance range to $6.65 to $6.85, up from the previous range of $6.55 to $6.85.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:42 am

AMD

Advanced Micro Devices, Inc. (AMD) shares fell nearly 2% in premarket trading after a lukewarm Q4 outlook. Despite reporting above-consensus Q3 earnings and revenue, the company's Q4 revenue guidance of $6.1 billion trailed most analysts' estimates. KeyBanc Capital Markets analyst John Vinh trimmed the price target for AMD shares from $160 to $140, maintaining an Overweight rating.

Portfolio Pulse from Shanthi Rexaline

November 01, 2023 | 10:40 am

CVS

CVS Health has confirmed its FY23 cash flow from operations guidance of $12.5B-$13.5B.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:39 am

ESAB

ESAB (NYSE:ESAB) reported Q3 2023 earnings of $1.08 per share, beating the analyst consensus estimate of $0.94 by 14.89%. This is a 17.39% increase over earnings of $0.92 per share from the same period last year. The company also reported quarterly sales of $681.00 million, beating the analyst consensus estimate of $632.15 million by 7.73%. This is a 9.79% increase over sales of $620.26 million the same period last year.

Portfolio Pulse from totan@benzinga.com

November 01, 2023 | 10:39 am

IDXX

IDEXX Laboratories has updated its FY2023 guidance, raising its EPS outlook from $9.64-$9.90 to $9.74-$9.90, while lowering its sales guidance from $3.66B-$3.71B to $3.64B-$3.65B. The company's full year revenue growth outlook range is now 7.9% - 8.4% as reported and 8.3% - 8.8% organically. The overall reported revenue range was decreased by $20 million due to updated foreign exchange impact estimates. The company's operating margin outlook has been raised to 29.6% - 29.8%.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:38 am

CVS

CVS Health has revised its GAAP EPS guidance downwards to $6.37-$6.61 from the previous $6.53-$6.75. However, the company has reaffirmed its adjusted EPS guidance of $8.50-$8.70, which is in line with the consensus of $8.58.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:38 am

MYE

Myers Indus (NYSE:MYE) reported Q3 earnings of $0.38 per share, missing the analyst consensus estimate of $0.43 by 11.63%. The company also reported quarterly sales of $197.80 million, missing the analyst consensus estimate of $220.74 million by 10.39%. This represents a decrease in earnings and sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:37 am